Express Scripts Reports First Quarter EPS of $0....( Raises 2009 EPS Guidance ST. L...),Health

Raises 2009 EPS Guidance

ST. LOUIS, April 29 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter net income from continuing operations of $214.7 million, or $0.86 per diluted share, which reflects 23% growth over $0.70 for the first quarter of 2008. The Company reported first quarter cash flow from continuing operations of $286.4 million, up 15% from $248.3 million last year.

"It has been a strong start to 2009 for Express Scripts. Our differentiated business model of alignment and behavior-centric approach is resonating in the marketplace and is translating into a successful start to the selling season," stated George Paz, president, chief executive officer and chairman.

"A new chapter in our history has begun with our proposed acquisition of WellPoint's NextRx subsidiaries. Our aligned business model, combined with the complementary expertise and capabilities of WellPoint creates significant opportunities for growth. We are well positioned to showcase our expertise in drug trend management and innovation in an environment where cost savings are so crucial for our plan sponsors and patients, while continuing to optimize health outcomes."

First Quarter 2009 Highlights

• The Company's generic utilization rate increased to 67.7% from 65.1% last year.
• Operating income increased 21% to $355.5 million from $294.6 million in the first quarter of 2008.
• EBITDA increased 19% to $380.1 million from $319.1 million last year and EBITDA per adjusted claim increased 24% to $3.06 from $2.46 last year.

The Company completed the integration of specialty pharmacy operations into its PBM operations. As a result, during the first quarter, the Company c
'/>"/>